CDK4/6 inhibitor - Globe Thesis

Keyword [CDK4/6 inhibitor] Result: 1 - 20 \| Page: 1 of 2
1.	The Effect Of CDK4/6 Inhibitor On MicroRNA Expression Profiling In Different Breast Cancer Cell Lines
2.	The Inhibitory Effect Of CDK4/6 Inhibitor PD-0332991on ESCC Cells And Its Related Molecular Mechanism
3.	The Mechanism Study Of Acquired Resistance Of EGFR-TKIs And Methods To Reverse It In NSCLC
4.	Metformin Inhibits M2-like Polarization Of Macrophage And Synergizes The Effect Of CDK4/6 Inhibitors Against Tumor Metastasis
5.	Efficacy And Safety Of CDK4/6 Inhibitors Combined With Endocrine Therapy In Advanced Breast Cancer: A Meta-analysis
6.	Anti-liver Cancer Activity And Mechanism Of Glycycoumarin
7.	Investigating The Therapeutic Effect Of Olaparib And Palbociclib In Ovarian Cancer And Its Underlying Mechanism
8.	Efficacy And Safety Of Molecular Targeted Drugs Combined With Endocrine Drugs In The Treatment Of Breast Cancer:A Meta-analysis
9.	Antitumor Activity Of A Novel CDK4/6 Inhibitor,SHR6390,in RB Positive Tumors
10.	New Synthetic Method And Anti-Proliferative Activity Study Of Ribociclib And Its Analogues
11.	HOTAIR-EZH2 Inhibitor AC1Q3QWB Upregulates CWF19L1 And Enhance Cell Cycle Inhibition Of CDK4/6 Inhibitor Palbociclib In Glioma
12.	Enhancement Of Radiosensitivity For Esophageal Squamous Cell Carcinoma By CDK4/6 Inhibitor
13.	Study On Protective Effect Of CDK4/6 Inhibitor Palbociclib In Diabetic Cardiomyopathy And Their Mechanisms
14.	Investigation On Anti-tumor Activity Of CDK4/6 Inhibitor In Non-small Cell Lung Cancer Cell Lines And The Mechanism Of Overcoming The Third Generation EGFR-TKI Acquired Resistance
15.	1.A CRISPR Knockout Negative Screen Reveals Synergy Between CDKs Inhibitor And Metformin In The Treatment Of Human Cancer 2.Methylation Silencing Of TGF-? Receptor Type ? Is Involved In Malignant Transformation Of Esophageal Squamous Cell Carcinoma
16.	CDK4/6 Inhibitor Palbociclib Enhances The Sensitivity Of RB-Proficient Triple-Negative Breast Cancer To Cisplatin
17.	The Anti-tumor Effect And Mechanism Of CDK4/6 Inhibitor Palbociclib In Small Cell Lungcancer Cell Lins
18.	The Role Of Osimertinib Combined With PD0332991 In EGFR-TKIs Resistant Lung Cancer Cells
19.	The Treatment Of KRAS Mutant Gastric Cancer And Its Mechanism By Dual-target Combination Therapy
20.	A Meta-Analysis Of Cyclin-Dependent Kinase 4/6 Inhibitors In Postmenopausal Patients With Hormone Receptor Positive,HER2-Negative Advanced Breast Cancer
<<First <Prev Next> Last>> Jump to